CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

PML::RARA fusion (APL)

Gene: PML::RARA · Type: fusion

Indications: Acute myeloid leukemia

Evidence Level Distribution

Level A: 2Level B: 4Level C: 6
LevelTypeDirectionSignificanceDiseaseDrugsRating
BPredictiveSupportsSensitivity/ResponseAcute Promyelocytic LeukemiaTretinoin5
ADiagnosticSupportsPositiveAcute Promyelocytic Leukemia5
APredictiveSupportsSensitivity/ResponseAcute Promyelocytic LeukemiaTretinoin,Arsenic Trioxide5
CPredictiveSupportsResistanceAcute Promyelocytic LeukemiaTretinoin4
BPredictiveSupportsResistanceAcute Promyelocytic LeukemiaArsenic Trioxide4
CDiagnosticSupportsPositiveAcute Promyelocytic Leukemia With PML-RARA4
CDiagnosticSupportsPositiveAcute Promyelocytic Leukemia With PML-RARA4
CDiagnosticSupportsPositiveAcute Promyelocytic Leukemia With PML-RARA4
BDiagnosticSupportsPositiveAcute Promyelocytic Leukemia With PML-RARA4
BDiagnosticSupportsPositiveAcute Promyelocytic Leukemia With PML-RARA4
CPredictiveSupportsResistanceAcute Promyelocytic LeukemiaTretinoin3
CPredictiveSupportsSensitivity/ResponseAcute Promyelocytic LeukemiaTretinoin3